Ben Lamm Represents The Potential Of Biotech, And Why We Should Keep Supporting Innovators
The rapid adoption of artificial intelligence in genetic engineering, health care, and medical research could lead to significant improvements in human health and our ecological environment in the decades ahead. But biotech innovators and entrepreneurs worldwide will have to overcome a global political environment that has suddenly become skeptical of science, expertise and public health in general.
Last week, 20,000 scientists, executives, investors and startups descended upon Boston for the BIO 2025 Convention – the largest medical research and biotech convening in the world. The convening took place amidst significant opportunity – and turmoil, in health care worldwide. The rapidly expanding capabilities of artificial intelligence are unlocking new opportunities to develop new drugs, therapeutics, wearables and devices. But BIO also comes at a time of significant declines in government funding for basic science and R&D, as well as a drop in global leadership around public health challenges like pandemic preparedness.
BIO 2025 Exhibition Hall
In 2025, the United States is expected to announce cuts of 40-60% to the National Institutes of Health and National Science Foundation. Yet American states are offering biotech's R&D credits, seed funding, lab space and commitments to improve their workforce and academic institutions. Nations around the world, sensing opportunity, are also rolling out the red carpet to attract the top scientists in the world. BIO itself highlighted the importance of building public trust in biotechnology and working with regulatory bodies to streamline approvals for innovative products.
Colossal Biosciences is a great example of a biotech startup at the intersection of these trends and challenges. Founded by legendary geneticist Dr. George Church of Harvard and MIT, and serial AI entrepreneur Ben Lamm, Colossal is pioneering the use of CRISPR technology in the de-extinction of previously lost species, including the Dire wolf. According to the International Union for the Conservation of Nature, nearly 50% of all animal species could be endangered of becoming extinct by 2050. According to Lamm, 'We are the back-up plan. It's like, when we jump out of a plane, we all hope the parachute is going to open, but just in case, we want to have a back-up emergency 'chute. Colossal is that back-up.'
The company defines de-extinction as the process of generating an organism that both resembles and is genetically similar to an extinct species by resurrecting its lost lineage of core genes; engineering natural resistances; and enhancing adaptability that will allow it to thrive in today's environment of climate change, dwindling resources, disease and human interference.
The Dire Wolf, as imagined by Colossal Biosciences
Such ambition and optimism were pervasive across BIO. Scores of startups today are using artificial intelligence for health care delivery, hospital operations, digital health platforms, diagnostics, patient monitoring tools, revenue cycle management, and even regulatory and compliance innovations. Biotech startups are using AI to improve drug discovery, target validation and optimize clinical trials. CRISPR, the ubiquitous gene editing tool now used in drug discovery, continues to improve as more genomes are mapped.
Colossal has developed a set of new software tools and technologies, along with CRISPR gene editing technology to resurrect these specific species but to also build a 'de-extinction toolkit' that can be used for difference animal species as needed. According to Chief Science Officer, Dr. Beth Shapiro, a world-renowned evolutionary molecular biologist and a leading figure in the field of ancient DNA and paleo genomics, 'we are developing a modular system that combines gene editing, cryopreservation, synthetic biology, and cloning to preserve, restore, and recreate species.'
As an example, the team at Colossal uses the genetics of the used the genetics of the closet relative of the team successfully used comparative genetics with its closest living relatives, the gray wolf, to fill in critical gaps in the genetic sequence. That cloning research that came from the project has immediate impacts on red wolf conservation and will serve as a critical tool for all canid restoration in the future.
The biotech industry worldwide continues to grow in importance, and no doubt there will be continued investment in the basic science, R&D and commercialization that drives important companies like Colossal and others. It is less clear whether that leadership will come from the United States or other nations – such as the United Arab Emirates, India, China, Japan or elsewhere? We don't know what areas of innovation those nations will prioritize, and whether or not important moonshots – like bringing back the woolly mammoth, will be on their radar. American leadership – scientific, political and financial, needs to remain committed to improving health of humans and the planet at large.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
6 Things to Avoid After 5 P.M. to Help Prevent Alzheimer's Disease, According to Dietitians
Reviewed by Dietitian Kelly Plowe, M.S., RDAge and genetics are risk factors for Alzheimer's disease, but lifestyle factors play a key role, too. Dietitians suggest avoiding alcohol, caffeine, heavy meals and sodium after 5 p.m to help reduce your risk. Regular exercise and eating a plant-based diet may also help prevent Alzheimer's it comes to protecting your brain health, what you do in the evening matters more than you might think. While you can't change risk factors like age or genetics, everyday habits can chip away at your brain's defenses or help strengthen them. Research shows that certain dietary choices and poor sleep may play a role in the development of Alzheimer's disease. The good news? A few simple changes to your evening routine can make an impactful difference. Some nighttime habits, like drinking sugar-sweetened beverages and consuming heavy meals, can disrupt sleep, increase inflammation and contribute to cognitive decline over time. Here's what experts recommend leaving out of your nightly routine to help lower your risk of Alzheimer's and support brain health. If you typically reach for a sweet tea or soda with dinner, it's worth reconsidering, especially if you want to support your brain health. 'Curbing sugary drinks in general, regardless of the time of day, is important for brain health and so much more,' says Sheri Gaw, RDN, CDCES. Gaw cites a study that found a considerably higher risk of dementia in participants who consumed seven servings of sugar-sweetened beverages per week. Excess added sugars have been linked to increased inflammation, insulin resistance and oxidative stress, all of which can negatively affect the brain over time. Instead of reaching for a sugary beverage, consider winding down with a glass of kefir. Along with being an excellent source of probiotics and protein, recent research suggests that drinking kefir may be beneficial for slowing Alzheimer's disease. Your nightly glass of wine could be interfering with one of the most important factors for brain health: sleep. 'Quality sleep is crucial to mental health and cognitive function, and drinking alcohol before bed can disrupt sleep quality,' explains Gaw. Alcohol interferes with the release of melatonin, the hormone that regulates sleep-wake cycles. Even small amounts of alcohol in the evening can fragment sleep cycles, reduce restorative deep sleep and lead to frequent nighttime awakenings., To support better sleep and long-term brain health, consider swapping that evening cocktail for a calming, alcohol-free alternative. Herbal teas like chamomile, rooibos and lavender can promote relaxation without disrupting sleep. And if you do choose to drink alcohol, limit how much you drink—no more than two drinks for men, one drink for women. Drinking caffeine too late in the day could prevent you from getting the sleep you need. 'Experts recommend at least seven to nine hours of sleep per night for brain health. Large doses of caffeine closer to bedtime impact sleep duration and quality,' says Gaw. 'Research shows that it's best to avoid coffee at least eight hours before bedtime, and steer clear of highly caffeinated pre-workout supplements at least 13 hours before sleep.' Since sleep plays a critical role in clearing waste products from the brain, including beta-amyloid proteins linked to Alzheimer's disease, protecting your rest is one of the simplest ways to support long-term cognitive health. If you're craving something warm in the evening, consider a caffeine-free herbal tea to help you ease into a restful night. 'High sodium intake has been linked to an increased risk of Alzheimer's disease, with research suggesting that excess sodium can trigger inflammation, reduce blood flow to the brain and damage blood vessels,', says Sheila Patterson, RD, CDCES. It may also lower levels of nitric oxide, a compound that helps relax blood vessels and support healthy circulation. To cut back, be mindful of sodium-packed foods, like canned soups, frozen meals, processed snacks or takeout. Instead, opt for whole, minimally processed options, and season meals with fresh herbs, citrus and salt-free spice blends to keep flavor high and sodium low. While dark chocolate is usually considered a healthy option, consuming it after 5 p.m. may hinder your ability to get the quality sleep you need. 'Dark chocolate is a sneaky source of caffeine and theobromine, two stimulants that can sabotage your sleep,' says Katharine Rosenthal, RD, LD. 'And poor sleep isn't just exhausting, it's one of the biggest long-term risk factors for cognitive decline.' Instead of reaching for dark chocolate after dinner, choose options that promote better sleep. Our Tart Cherry Nice Cream is the perfect snack for a restful night's sleep due to its sleep-inducing ingredients. It's a great way too satisfy your sweet tooth while potentially helping yourself catch more zzz's and stave off neurodegenerative diseases. 'Try to avoid heavy meals at night for better sleep and optimal cognitive function,' Gaw recommends. 'Eating too close to bedtime may disrupt digestion, causing indigestion, discomfort and poor sleep quality.' To support better sleep and brain health, aim to finish your last substantial meal at least two to three hours before going to bed. In the evening, opt for lighter, balanced options. The best choices offer fiber, healthy fats and protein to help keep you satisfied without weighing you down. Eat more . 'Antioxidant-rich foods play a crucial role in promoting healthy aging and maintaining cognitive function by reducing oxidative stress and inflammation—two factors linked to age-related diseases like Alzheimer's,' says Lindsay Fencl, RD, CD. 'Add more berries, walnuts and dark leafy greens to your diet,' she recommends. Eat a plant-forward diet. Consume a low-sodium, well-balanced and colorful diet, such as the MIND diet. 'The MIND diet (a combination of the Mediterranean and the Dietary Approaches to Stop Hypertension diets) supports brain function with a focus on berries, whole grains, nuts, seeds, fish, beans and leafy greens,' says Gaw. Not sure where to start? Supplement with creatine. Numerous studies conducted over the past decade suggest that creatine supplementation can significantly enhance memory, attention and processing speed. 'A recent study in Alzheimer's patients found that supplementing with 20 grams of creatine was associated with improvements in cognition,' says Fencl. While these results are promising, the study was small, and more research is needed. Move your body often. Studies show that exercise may help reduce the risk of Alzheimer's disease. If exercise isn't currently part of your routine, start where you're at. Find something you enjoy and can stick to. Whether it's walking, bicycling or yoga, all movement is worthwhile. The best way to support brain health and help prevent Alzheimer's disease is through healthy, sustainable habits. To help lower your long-term risk of cognitive decline, skip the nightly sugar-sweetened beverages, evening alcohol, excess caffeine intake and heavy meals. Instead, focus on a plant-forward, antioxidant-rich diet, like the MIND diet, and regular exercise. You don't have to overhaul your current lifestyle habits completely. Small changes can lead to big results over time. Read the original article on EATINGWELL
Yahoo
an hour ago
- Yahoo
3 Reasons to Buy Solana Instead of Ethereum and 1 Reason Not To
Solana is gaining ground against Ethereum in a few different domains. Its chain is better positioned to win in segments like AI and DePIN. That doesn't mean you should let your expectations for its growth get unmoored. 10 stocks we like better than Ethereum › If Ethereum (CRYPTO: ETH) is the eight‑lane interstate of smart‑contract blockchains, Solana (CRYPTO: SOL) feels more like a bullet train. Both chains reach the same destinations, but one arrives faster, cheaper, and with fewer inconveniences along the way. That's why many longtime crypto investors are wondering whether now is the moment to swap some Ether for Solana, assuming they haven't already. Solana enjoys three durable edges that even Ethereum's recent Pectra upgrade hasn't erased. Let's take a peek at each and understand why it might be worth hopping onboard with Solana. Solana's chain regularly posts real‑world throughput above 1,000 transactions per second (TPS) and transaction times near 0.4 seconds. In contrast, Ethereum's base layer still crawls at roughly 15 to 30 TPS, and its transactions are trapped within the chain's 12‑second blocks. For users who want snappier performance with Ethereum, it's necessary to bridge capital to one of its layer‑2 (L2) subchains, which is an additional step, plus sometimes it requires different tooling, thereby adding a lot of friction. The raw numbers matter most for latency‑sensitive segments like on‑chain artificial intelligence (AI) and decentralized physical infrastructure networks (DePIN). One Solana‑based DePIN project called Roam crossed 2.5 million registered users in March 2025. A spike in usage of that magnitude would swamp most Ethereum L2s before breakfast, not to mention completely clogging up the main chain. The takeaway here is that Solana is already handling traffic that would immediately break Ethereum's highest‑throughput pipes for everyone. Higher speeds also simplify developer life. Building a real‑time AI data marketplace or a global mapping protocol is easier when a chain's transaction confirmations arrive in under a second, and finality is nearly instantaneous. Ethereum could close the speed gap over time, but Solana owns it today. A typical Solana transaction costs between $0.0001 and $0.0025. Ethereum's layer‑1 average gas fee for a token swap was about $5.55 on the morning of June 25, and it often spikes above $15 when traffic is high. The days of gas fees in the $60 range are probably over, but compared with fees that are nearly free, even a few dollars feels like a lot. For investors, that difference between the two chains compounds quickly. Automated trading bots or decentralized finance (DeFi) strategies that make sense at Solana's fee levels can be dead on arrival on Ethereum. Cheap fees also help to onboard new users -- a demographic every network ultimately needs to thrive. Solana‑based coins captured a lot of attention in 2024 and early 2025; Ethereum's ecosystem, in large part, did not. Part of that gap is technical. Ethereum's 140‑plus alternative layers create liquidity silos, reliance on a plethora of bridges for capital, and an endless pile of unique tooling for basic tasks like wallet access or scanning certificates to verify asset provenance. Solana's monolithic design avoids those headaches. Furthermore, the chain's publicly posted development roadmap emphasizes focusing on throughput bumps, institutional onboarding, and smoother tooling throughout 2025. These narratives matter in crypto. When people believe a chain feels intuitive, the flywheel of builders, users, and capital spins faster. And right now, that reputational tailwind is blowing harder for Solana than for Ethereum. Don't confuse Solana's edge with having explosive upside. At roughly a $77.5 billion market cap versus Ethereum's $290.4 billion, Solana already trades like a blue chip. It isn't a smart move to sell your Ethereum in hopes of investing in Solana and then having that coin subsequently go to the moon. Could it one day overtake Ethereum? Probably. In fact, I'd bet on it happening eventually, at least as of right now. But that would still be "only" a 4X return, not the 100‑bagger fantasy that some holders whisper about. Don't fall for that kind of thinking even if you're optimistic here. Long‑term investors should see Solana as a calculated bet on speed, cost efficiency, and execution, not a ticket to instant riches. Before you buy stock in Ethereum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Ethereum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Alex Carchidi has positions in Ethereum and Solana. The Motley Fool has positions in and recommends Ethereum and Solana. The Motley Fool has a disclosure policy. 3 Reasons to Buy Solana Instead of Ethereum and 1 Reason Not To was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
3 Ways the Genius Act Could Affect the Cryptocurrency Sector Over the Next 5 Years
The Genius Act, regulating stablecoins, just passed the Senate. It still needs to pass a House vote and avoid veto before becoming law. It will change a handful of big features about the crypto sector if it's adopted. 10 stocks we like better than XRP › On June 17, the U.S. Senate passed the Guiding and Establishing National Innovation for U.S. Stablecoins (Genius) Act, vaulting the first comprehensive federal stablecoin framework over its biggest hurdle. The bill now heads to the House, where the Financial Services Committee is preparing its own text for conference negotiations and potentially a vote later this summer. It could be signed into law before the fall, reshaping the cryptocurrency landscape in a major way. The act's mix of strict reserve mandates and nationwide licensing has the power to determine which blockchains are favored, which projects matter, which tokens are used, and thus where the next wave of liquidity lands. Let's dig in and take a look at three of the biggest ways the legislation could make waves, assuming it gets signed into law. The Senate bill would create a new "permitted payment stablecoin issuer" charter and requires every token to be backed 1:1 with cash, U.S. Treasuries, or overnight repurchase agreements (repos) -- all audited annually for issuers above $50 billion in circulation. This is a distinct change from the present Wild West system, in which there are few meaningful safeguards or reserve requirements. That clarity hits just as stablecoins have become the dominant medium of exchange on blockchains. In 2024, they accounted for roughly 60% of all crypto transfer value and processed 1.5 million transactions a day, most less than $10,000. For everyday payments, a stablecoin token that never drifts from $1 is simply more useful than most legacy payment‑focused altcoins, whose price can swing 5% before lunch. Once U.S.‑licensed stablecoins can move legally across state lines, merchants that still accept volatile coins will be hard‑pressed to justify the extra risk. During the next few years, those altcoins may see their utility severely erode along with their investment thesis, if they can't pivot. Even if the Senate's bill doesn't pass in its current form, the writing is on the wall. The long-term incentives will tilt sharply toward dollar‑pegged payment rails rather than payment-focused altcoins. The new regulations wouldn't just bless stablecoins; if the bill is signed into law, eventually it will effectively funnel these coins to blockchains that can satisfy auditors and risk officers. Ethereum (CRYPTO: ETH) already hosts about $130.3 billion worth of stablecoins, far more than any rival. Its mature decentralized finance (DeFi) stack means issuers can plug into lending pools, collateral lockers, and analytics out of the box. They can also duct-tape together a set of regulatory compliance modules and best practices so as to try to appease regulatory requirements. In contrast, the XRP (CRYPTO: XRP) Ledger (XRPL) is positioning itself as the compliance‑first home for tokenized money, including for stablecoins. In the last month alone, fully backed stablecoin tokens have launched on XRP Ledger, each touting built‑in tools for account freezes, blacklists, and identity screening. Those features align neatly with the Senate bill's requirement that issuers maintain robust redemption and money‑laundering controls. Ethereum's compliance stack could potentially leave issuers in violation of that mandate, but it's difficult to say exactly how stringent regulators' requirements are on that front as of now. Nonetheless, if the bill becomes law in its current form, large issuers will need real‑time verifications and turnkey know-your-customer (KYC) hooks to stay even approximately in good standing. Ethereum offers flexibility at the expense of complicated technical implementations, whereas XRP offers top‑down control on a streamlined platform. Both chains look advantaged at the moment, at least in comparison to privacy‑centric chains or speed-focused chains, which may struggle to meet the same requirements without expensive retrofits. Because every dollar stablecoin must sit on a matched reserve of cash-like assets, the act quietly ties crypto liquidity to U.S. short‑term debt. The stablecoin market already tops $251 billion. It could grow to reach $500 billion by 2026 if institutional adoption stays on its current path. At that scale, stablecoin issuers would be among the largest buyers of U.S. Treasury bills, recycling the yield to fund redemptions or customer rewards. For blockchains, the connection matters in two ways. First, the demand for more reserves means that more corporate balance sheets will be holding Treasuries while simultaneously holding native coins to pay network fees, thereby driving organic demand for coins like Ethereum and XRP. Second, stablecoin interest revenue could underwrite aggressive user incentives. If issuers send back part of their Treasury yield to holders, spending stablecoins rather than using a credit card might becomes the rational choice for some investors, accelerating on‑chain payment volume and fee throughput. Assuming the House keeps the reserve language intact, investors should expect increased monetary sensitivity as well. If regulators tweak collateral eligibility or the Federal Reserve shifts bill supply, stablecoin growth and crypto liquidity will move in lockstep. That is a risk worth noting, but also a sign that digital assets are entering the mainstream of capital markets rather than standing apart from them from here on out. Before you buy stock in XRP, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and XRP wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $704,676!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $950,198!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Alex Carchidi has positions in Ethereum. The Motley Fool has positions in and recommends Ethereum and XRP. The Motley Fool has a disclosure policy. 3 Ways the Genius Act Could Affect the Cryptocurrency Sector Over the Next 5 Years was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
